Navigation Links
Ventas Grants Stock Awards to Promote Long-Term Retention and Reward Performance
Date:12/5/2007

LOUISVILLE, Ky., Dec. 5 /PRNewswire-FirstCall/ -- Ventas, Inc. (NYSE: VTR) ("Ventas" or the "Company") announced today that the Executive Compensation Committee of its Board of Directors has granted special restricted stock awards to certain executive officers to encourage their long-term retention and reward performance. The awards were granted to Raymond J. Lewis, the Company's Chief Investment Officer, Richard A. Schweinhart, the Company's Chief Financial Officer, and T. Richard Riney, the Company's Chief Administrative Officer and General Counsel.

"Ray, Rick and Rick have been essential to Ventas's success. I am exceedingly happy that the Compensation Committee has recognized their significant contributions to the Company, and look forward to working with each of them in the coming years," said Ventas Chairman, President and Chief Executive Officer Debra A. Cafaro.

Mr. Lewis has been awarded 45,871 restricted shares of the Company's common stock, vesting one-third on the third anniversary of the date of grant, one-third on the fourth anniversary of the date of grant and one-third on the fifth anniversary of the date of grant. Messrs. Schweinhart and Riney each received 22,935 restricted shares of the Company's common stock, vesting on the same schedule.

Ventas, Inc. is a leading healthcare real estate investment trust. Its diverse portfolio of properties located in 43 states and two Canadian provinces includes seniors housing communities, skilled nursing facilities, hospitals and medical office and other properties. More information about Ventas can be found on its website at http://www.ventasreit.com.

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding Ventas, Inc.'s ("Ventas" or the "Company") and its s
'/>"/>

SOURCE Ventas, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Ventas Declares Regular Quarterly Dividend of $0.475 Per Share
2. Ventas Board Names Ronald G. Geary Audit Committee Chair; Appoints Douglas Crocker II to Fill Vacancy on Audit Committee
3. Ventas Announces 2007 Third Quarter Earnings Release Date and Conference Call
4. Ventas Appoints Brush SVP - Senior Housing Development and Operations
5. Ventas Declares Regular Quarterly Dividend of $0.475 Per Share
6. U.S. Labor Department Awards $10.1 Million for Safety and Health Training Grants
7. Sunesis Pharmaceuticals Reports New Option Grants Under NASDAQ Marketplace Rule 4350
8. American Cancer Society awards research grants to 109 investigators at 77 institutions nationwide
9. USAID Announces First Malaria Communities Program Grants
10. The Highmark Foundation Awards $580,000 in Highmark Healthy High 5 Grants to Four Non-Profit Organizations
11. KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2015)... May 24, 2015 Women's Excellence ... hair loss. Although it is unclear about the etiology ... environmental factors such as metabolism, nutritional deficiencies, thyroid abnormalities ... offer a comprehensive approach to evaluating the metabolic, nutritional ... they can help patients find a cause for their ...
(Date:5/24/2015)... Scientists with Cardno ChemRisk, a scientific consulting ... issues that may have raised the risk of mesothelioma ... posted an article on the research. Click here ... airborne asbestos levels well above OSHA safety guidelines when ... , “Asbestos compliance sampling data associated with the construction, ...
(Date:5/24/2015)... ProPin is a set of self-animating 3D ... Utilize ProPin to pin point locations on a map, to indicate ... ProPin allows users to choose from 30 simplistic presets with geometric ... controls, video editors can easily manipulate ProPin presets as a whole. ... absolute ease. , Using ProPin is easy, simply drag a preset ...
(Date:5/24/2015)... (PRWEB) May 24, 2015 ... System CEO - The students ... honored at the fourth annual A ... 15 at Geneva National in Lake ... ,     -Badger High School,         Jonathan Alfonso, ...
(Date:5/23/2015)... Washington, D.C. (PRWEB) May 23, 2015 ... demonstration of powers of a youngster's yogic power learned ... by Sri Nithyananda Swami in Bangalore, India. , Yogamaatha, ... of more than 50 high profile professionals attending the ... D.C. by reading fluently -- blindfolded. , In ...
Breaking Medicine News(10 mins):Health News:Women's Excellence Now Treats Menopausal Hair Loss 2Health News:New Analysis Finds Too Many Employers Ignored OSHA Asbestos Guidelines, According to Surviving Mesothelioma 2Health News:Developers at Pixel Film Studios Release ProPin for Final Cut Pro X. 2Health News:Mercy Foundation Honors 16 Students for Making a Difference - Mercy Health System Javon Bea 2Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 2Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 3
... save more in treatment costs under Medicare and ... according to a recent study. , "Chronic conditions ... and employers," said Dennis Scanlon, professor of health ... of the study. "Assessing the financial impact of ...
... method uncovered more players in painful gastrointestinal condition ... international team of researchers has pinpointed new genetic ... chronic and painful condition caused by inflammation of ... Philadelphia-led group used a new gene-searching method, combining ...
... Must Reform Ineffective 33-year-old Chemicals Law, Expert Testifies WASHINGTON, ... nation,s main chemicals law, the Toxic Substances Control Act ... the safety of the tens of thousands of chemicals ... conclusion of expert testimony provided at a hearing ...
... The powerful chemotherapy and radiation used to save cancer ... Research in a new field called oncofertility has advanced ... of women, men and children who are diagnosed with ... strategies to help their patients. , A leading oncofertility ...
... As the voice of the global clinical ... (ACRO) had the honor of presenting before the ... 2009 in Tokyo. ACRO Chair Derek Winstanly, MBChB, ... ACRO Executive Director Douglas Peddicord, Ph.D. addressed "Representing ...
... Pack Your Bag(TM) Program Brings Educational Outreach to ... out of ten older Americans have at least ... pressure or diabetes. With many of these older ... risk for drug interactions when certain medications are ...
Cached Medicine News:Health News:Team-based diabetes care fetches more value for dollar 2Health News:Scientists Discover New Drug Targets for Crohn's Disease 2Health News:Main U.S. Toxics Law Failing to Ensure Safety of Thousands of Chemicals 2Health News:Main U.S. Toxics Law Failing to Ensure Safety of Thousands of Chemicals 3Health News:New tool guides doctors to save cancer patients' fertility 2Health News:New tool guides doctors to save cancer patients' fertility 3Health News:ACRO Presents at Japan CRO Association Commemorative Symposium 2Health News:Video: CVS/pharmacy and National Council on Aging Kick Off Medication Management Program for Seniors 2Health News:Video: CVS/pharmacy and National Council on Aging Kick Off Medication Management Program for Seniors 3
(Date:5/22/2015)... THOUSAND OAKS, Calif. , May 22, ... today announced the Company has commenced termination ... commercialization of brodalumab with AstraZeneca (LON:AZN, STO:AZN ... investigational IL-17 inhibitor, is in development for ... and axial spondyloarthritis.  The decision was based ...
(Date:5/22/2015)... May 22, 2015 The Assistance Fund announces ... program provides financial assistance for copay to individuals diagnosed ... announce the addition of the Melanoma Copay Assistance Program ... McGreevy , executive director. "With each additional program we ... a world where no one is denied access to ...
(Date:5/22/2015)... May 22, 2015  The U.S. Food and ... -- the first biosimilar product approved in ... toward growth in the contract manufacturing organization (CMO) ... industry is geared to the production of small-molecular ... biopharmaceutical products. The healthcare market research publisher,s report, ...
Breaking Medicine Technology:Amgen to terminate participation in co-development and commercialization of brodalumab 2Amgen to terminate participation in co-development and commercialization of brodalumab 3Amgen to terminate participation in co-development and commercialization of brodalumab 4Amgen to terminate participation in co-development and commercialization of brodalumab 5The Assistance Fund Adds Melanoma Assistance Program 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 4
... April 26, 2012 Upsher-Smith Laboratories, Inc. ( ... the pharmacokinetic (PK) profile of USL255, its once-daily, ... 64th Annual American Academy of Neurology (AAN) Meeting.  ... USL255 and equal doses of immediate-release (IR) topiramate ...
... effects of Neupro ® (rotigotine transdermal system) on ... today at the 64th AAN Annual Meeting in New ... data from five, randomized, double-blind,  placebo-controlled trials investigated the ... fatigue in patients with PD. Improvements were observed with ...
Cached Medicine Technology:Upsher-Smith Research Shows Unique Pharmacokinetic Profile of USL255 Extended Release Topiramate 2Upsher-Smith Research Shows Unique Pharmacokinetic Profile of USL255 Extended Release Topiramate 3Upsher-Smith Research Shows Unique Pharmacokinetic Profile of USL255 Extended Release Topiramate 4Upsher-Smith Research Shows Unique Pharmacokinetic Profile of USL255 Extended Release Topiramate 5New post-hoc analyses examined Neupro® effects on pain, depressed mood, apathy and fatigue in patients with Parkinson's disease 2New post-hoc analyses examined Neupro® effects on pain, depressed mood, apathy and fatigue in patients with Parkinson's disease 3New post-hoc analyses examined Neupro® effects on pain, depressed mood, apathy and fatigue in patients with Parkinson's disease 4New post-hoc analyses examined Neupro® effects on pain, depressed mood, apathy and fatigue in patients with Parkinson's disease 5New post-hoc analyses examined Neupro® effects on pain, depressed mood, apathy and fatigue in patients with Parkinson's disease 6New post-hoc analyses examined Neupro® effects on pain, depressed mood, apathy and fatigue in patients with Parkinson's disease 7New post-hoc analyses examined Neupro® effects on pain, depressed mood, apathy and fatigue in patients with Parkinson's disease 8New post-hoc analyses examined Neupro® effects on pain, depressed mood, apathy and fatigue in patients with Parkinson's disease 9New post-hoc analyses examined Neupro® effects on pain, depressed mood, apathy and fatigue in patients with Parkinson's disease 10
RapidStrep A test is a qualitative test that detects group A,streptococcal antigen. The test is a rapid, in vitro assay. It is,intended for professional use to help diagnose Strep A,infection i...
... caused by the intracellular parasite Toxoplasma gondii ... or by contract with cat,feces containing oocytes. ... be passed to the fetus through the ... is a cause of mortality and malformation.,This ...
... an immunochromatographic in vitro assay,for detection ... infection.,Infectious mononucleosis (IM) is caused by ... is based on detection of,serum antibodies ... the,heterophile antibodies present in the sera ...
Inquire...
Medicine Products: